Business Apellis Pharmaceuticals' Empaveli sNDA action date extended by FDA By Chelsea Newton On Mar 16, 2023 Share Apellis Pharmaceuticals' Empaveli sNDA action date extended by FDA Source Link 7149 487 174 175 8339 Share FacebookTwitterGoogle+ReddItWhatsAppPinterestEmail
Comments are closed, but trackbacks and pingbacks are open.